Next 10 |
home / stock / podd / podd articles
U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Shares of Surgery Partners, Inc. (NASDAQ: SGRY) fe...
U.S. stocks could see a pause on Friday as traders take a breather following the impressive rally on Thursday, sparked by Nvidia Corp.’s (...
Investors pinned hopes on Nvidia Corp.’s (NASDAQ:NVDA) earnings to reinvigorate market momentum, and the AI leader delivered an impressive ...
The markets exhibited a mixed trend Monday, with technology heavyweights experienced a slight downturn as investors adopt a cautious approach ahead...
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read. In "Buy Chevron Stock. ...
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s sessio...
Insulet Corporation (NASDAQ: PODD) reported Q3 sales of $432.7 million, up 27.0%, or 25.1% in constant currency, beating the consensus of...
Insulet Corporation (NASDAQ: PODD) shares traded lower Thursday. The stock has been under pressure this year amid the popularity of weight loss dru...
Benzinga AI Powerhouse: Palantir And PwC Team Up To Accelerate Data-Driven Operations Palantir Technologies Inc (NYSE: PLTR) is expanding its...
News, Short Squeeze, Breakout and More Instantly...
2024-04-23 22:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the first quarter of 2024 on May 9, 2024 after the close of the financial mar...